DATA SEKUNDER

BERDASARKAN KELOMPOK/DOSIS
1. DOSIS 1
Tests of Normality

Kolmogorov-Smirnova Shapiro-Wilk

Jam Statistic df Sig. Statistic df Sig.

Neutrofil Jam ke-0 .141 6 .200* .973 6 .913

Jam ke-4 .190 6 .200* .941 6 .663

Jam ke-8 .306 6 .082 .827 6 .101

Jam ke-12 .267 6 .200* .910 6 .439

*. This is a lower bound of the true significance.

a. Lilliefors Significance Correction

Test of Homogeneity of Variances

Neutrofil

Levene Statistic df1 df2 Sig.

3 20 .798
.338

ANOVA
Neutrofil

Sum of Squares df Mean Square F Sig.

Between Groups 249.792 3 83.264 4.050 .021

Within Groups 411.167 20 20.558
Total 660.958 23
 Multiple Comparisons
Dependent Variable: Neutrofil
LSD

Mean 95% Confidence Interval

(I) Jam (J) Jam Difference (I-J) Std. Error Sig. Lower Bound Upper Bound

Jam ke-0 Jam ke-4 -8.000* 2.618 .006 -13.46 -2.54

Jam ke-8 -1.167 2.618 .661 -6.63 4.29

Jam ke-12 -.667 2.618 .802 -6.13 4.79

Jam ke-4 Jam ke-0 8.000* 2.618 .006 2.54 13.46
Jam ke-8 6.833* 2.618 .017 1.37 12.29
Jam ke-12 7.333* 2.618 .011 1.87 12.79
Jam ke-8 Jam ke-0 1.167 2.618 .661 -4.29 6.63
Jam ke-4 -6.833* 2.618 .017 -12.29 -1.37
Jam ke-12 .500 2.618 .850 -4.96 5.96
Jam ke-12 Jam ke-0 .667 2.618 .802 -4.79 6.13

Jam ke-4 -7.333* 2.618 .011 -12.79 -1.87

Jam ke-8 -.500 2.618 .850 -5.96 4.96

*. The mean difference is significant at the 0.05 level.

2. DOSIS 2
Tests of Normality

Kolmogorov-Smirnova Shapiro-Wilk

Jam Statistic df Sig. Statistic df Sig.

Neutrofil Jam ke-0 .299 6 .100 .851 6 .161

Jam ke-4 .204 6 .200* .853 6 .168

Jam ke-8 .239 6 .200* .851 6 .162

Jam ke-12 .221 6 .200* .926 6 .548

*. This is a lower bound of the true significance.

a. Lilliefors Significance Correction

Test of Homogeneity of Variances

Neutrofil

Levene Statistic df1 df2 Sig.

2.521 3 20 .087

ANOVA
Neutrofil
Sum of Squares df Mean Square F Sig.

Between Groups 353.500 3 117.833 8.117 .001

Within Groups 290.333 20 14.517
Total 643.833 23
 Multiple Comparisons
Dependent Variable: Neutrofil
LSD

Mean 95% Confidence Interval

(I) Jam (J) Jam Difference (I-J) Std. Error Sig. Lower Bound Upper Bound

Jam ke-0 Jam ke-4 -8.500* 2.200 .001 -13.09 -3.91

Jam ke-8 -3.333 2.200 .145 -7.92 1.26

Jam ke-12 1.500 2.200 .503 -3.09 6.09

Jam ke-4 Jam ke-0 8.500* 2.200 .001 3.91 13.09
Jam ke-8 5.167* 2.200 .029 .58 9.76
Jam ke-12 10.000* 2.200 .000 5.41 14.59
Jam ke-8 Jam ke-0 3.333 2.200 .145 -1.26 7.92
Jam ke-4 -5.167* 2.200 .029 -9.76 -.58
Jam ke-12 4.833* 2.200 .040 .24 9.42
Jam ke-12 Jam ke-0 -1.500 2.200 .503 -6.09 3.09

Jam ke-4 -10.000* 2.200 .000 -14.59 -5.41

Jam ke-8 -4.833* 2.200 .040 -9.42 -.24

*. The mean difference is significant at the 0.05 level.

3. DOSIS 3
Tests of Normality

Kolmogorov-Smirnova Shapiro-Wilk

Jam Statistic df Sig. Statistic df Sig.

Neutrofil Jam ke-0 .159 6 .200* .958 6 .801

Jam ke-4 .322 6 .051 .791 6 .048

Jam ke-8 .285 6 .139 .779 6 .037

Jam ke-12 .187 6 .200* .966 6 .866

*. This is a lower bound of the true significance.

a. Lilliefors Significance Correction

Test of Homogeneity of Variances

Neutrofil

Levene Statistic df1 df2 Sig.

1.132 3 20 .360

Test Statisticsa,b

Neutrofil
Chi-Square 13.354
df 3
Asymp. Sig. .004
a. Kruskal Wallis Test
b. Grouping Variable: Jam

Mann-Whitney Test
I (Jam) II (Jam) Asymp. Sig.
Jam ke-0 Jam ke-4 .004
Jam ke-8 .107
Jam ke-12 .936
Jam ke-4 Jam ke-8 .037
Jam ke-12 .004
Jam ke-8 Jam ke-12 .126

4. KONTROL POSITIF
Tests of Normality

Kolmogorov-Smirnova Shapiro-Wilk

Jam Statistic df Sig. Statistic df Sig.

Neutrofil Jam ke-0 .122 6 .200* .982 6 .961

Jam ke-4 .191 6 .200* .938 6 .647

Jam ke-8 .237 6 .200* .936 6 .628

Jam ke-12 .190 6 .200* .882 6 .277

*. This is a lower bound of the true significance.

a. Lilliefors Significance Correction

Test of Homogeneity of Variances

Neutrofil
Levene Statistic df1 df2 Sig.

2.749 3 20 .070

ANOVA
Neutrofil

Sum of Squares df Mean Square F Sig.

Between Groups 252.333 3 84.111 2.787 .067

Within Groups 603.667 20 30.183
Total 856.000 23
 Multiple Comparisons
Dependent Variable: Neutrofil
LSD

Mean 95% Confidence Interval

(I) Jam (J) Jam Difference (I-J) Std. Error Sig. Lower Bound Upper Bound

Jam ke-0 Jam ke-4 -7.667* 3.172 .025 -14.28 -1.05

Jam ke-8 -2.833 3.172 .382 -9.45 3.78

Jam ke-12 .500 3.172 .876 -6.12 7.12

Jam ke-4 Jam ke-0 7.667* 3.172 .025 1.05 14.28
Jam ke-8 4.833 3.172 .143 -1.78 11.45
Jam ke-12 8.167* 3.172 .018 1.55 14.78
Jam ke-8 Jam ke-0 2.833 3.172 .382 -3.78 9.45
Jam ke-4 -4.833 3.172 .143 -11.45 1.78
Jam ke-12 3.333 3.172 .306 -3.28 9.95
Jam ke-12 Jam ke-0 -.500 3.172 .876 -7.12 6.12

Jam ke-4 -8.167* 3.172 .018 -14.78 -1.55

Jam ke-8 -3.333 3.172 .306 -9.95 3.28

*. The mean difference is significant at the 0.05 level.

5. KONTROL NEGATIF
Tests of Normality

Kolmogorov-Smirnova Shapiro-Wilk

Jam Statistic df Sig. Statistic df Sig.

Neutrofil Jam ke-0 .172 6 .200* .912 6 .452

Jam ke-4 .215 6 .200* .850 6 .158

Jam ke-8 .221 6 .200* .872 6 .232

Jam ke-12 .343 6 .027 .805 6 .065

*. This is a lower bound of the true significance.

a. Lilliefors Significance Correction

Test of Homogeneity of Variances

Neutrofil

Levene Statistic df1 df2 Sig.

1.599 3 20 .221

ANOVA
Neutrofil
Sum of Squares df Mean Square F Sig.

Between Groups 839.125 3 279.708 12.061 .000

Within Groups 463.833 20 23.192
Total 1302.958 23
 Multiple Comparisons
Dependent Variable: Neutrofil
LSD

Mean 95% Confidence Interval

(I) Jam (J) Jam Difference (I-J) Std. Error Sig. Lower Bound Upper Bound

Jam ke-0 Jam ke-4 -16.000* 2.780 .000 -21.80 -10.20

Jam ke-8 -10.833* 2.780 .001 -16.63 -5.03

Jam ke-12 -6.000* 2.780 .043 -11.80 -.20

Jam ke-4 Jam ke-0 16.000* 2.780 .000 10.20 21.80
Jam ke-8 5.167 2.780 .078 -.63 10.97
Jam ke-12 10.000* 2.780 .002 4.20 15.80
Jam ke-8 Jam ke-0 10.833* 2.780 .001 5.03 16.63
Jam ke-4 -5.167 2.780 .078 -10.97 .63
Jam ke-12 4.833 2.780 .098 -.97 10.63
Jam ke-12 Jam ke-0 6.000* 2.780 .043 .20 11.80

Jam ke-4 -10.000* 2.780 .002 -15.80 -4.20

Jam ke-8 -4.833 2.780 .098 -10.63 .97

*. The mean difference is significant at the 0.05 level.

BERDASARKAN WAKTU
1. JAM KE-0
Tests of Normality

Kolmogorov-Smirnova Shapiro-Wilk

Kelompok Statistic df Sig. Statistic df Sig.

Neutrofil Kontrol Negatif .172 6 .200* .912 6 .452

Dosis 1 .141 6 .200* .973 6 .913

Dosis 2 .299 6 .100 .851 6 .161

Dosis 3 .159 6 .200* .958 6 .801

Kontrol Positif .122 6 .200* .982 6 .961

*. This is a lower bound of the true significance.

a. Lilliefors Significance Correction

Test of Homogeneity of Variances

Neutrofil

Levene Statistic df1 df2 Sig.

.369 4 25 .829

ANOVA
Neutrofil

Sum of Squares df Mean Square F Sig.

Between Groups 27.867 4 6.967 1.405 .261

Within Groups 124.000 25 4.960
Total 151.867 29
 Multiple Comparisons
Dependent Variable: Neutrofil
LSD

Mean Difference 95% Confidence Interval

(I) Kelompok (J) Kelompok (I-J) Std. Error Sig. Lower Bound Upper Bound

Kontrol Negatif Dosis 1 2.333 1.286 .082 -.31 4.98

Dosis 2 -.500 1.286 .701 -3.15 2.15

Dosis 3 .667 1.286 .609 -1.98 3.31

Kontrol Positif .333 1.286 .798 -2.31 2.98

Dosis 1 Kontrol Negatif -2.333 1.286 .082 -4.98 .31
Dosis 2 -2.833* 1.286 .037 -5.48 -.19
Dosis 3 -1.667 1.286 .207 -4.31 .98
Kontrol Positif -2.000 1.286 .132 -4.65 .65
Dosis 2 Kontrol Negatif .500 1.286 .701 -2.15 3.15
Dosis 1 2.833* 1.286 .037 .19 5.48
Dosis 3 1.167 1.286 .373 -1.48 3.81
Kontrol Positif .833 1.286 .523 -1.81 3.48
Dosis 3 Kontrol Negatif -.667 1.286 .609 -3.31 1.98
Dosis 1 1.667 1.286 .207 -.98 4.31
Dosis 2 -1.167 1.286 .373 -3.81 1.48
Kontrol Positif -.333 1.286 .798 -2.98 2.31
Kontrol Positif Kontrol Negatif -.333 1.286 .798 -2.98 2.31

Dosis 1 2.000 1.286 .132 -.65 4.65

Dosis 2 -.833 1.286 .523 -3.48 1.81

Dosis 3 .333 1.286 .798 -2.31 2.98

*. The mean difference is significant at the 0.05 level.

2. JAM KE-4
Tests of Normality

Kolmogorov-Smirnova Shapiro-Wilk

Kelompok Statistic df Sig. Statistic df Sig.

Neutrofil Kontrol Negatif .215 6 .200* .850 6 .158

Dosis 1 .314 6 .066 .773 6 .033

Dosis 2 .204 6 .200* .853 6 .168

Dosis 3 .322 6 .051 .791 6 .048

Kontrol Positif .191 6 .200* .938 6 .647

*. This is a lower bound of the true significance.

a. Lilliefors Significance Correction
 Test of Homogeneity of Variances
Neutrofil

Levene Statistic df1 df2 Sig.

1.643 4 25 .195

Test Statisticsa,b

Neutrofil

Chi-Square 9.991
df 4
Asymp. Sig. .041

a. Kruskal Wallis Test

b. Grouping Variable:
Kelompok

Mann-Whitney Test
I (Dosis) II (Dosis) Asymp. Sig.
KN Dosis 1 .054
Dosis 2 .012
Dosis 3 .053
KP .020
Dosis 1 Dosis 2 .076
Dosis 3 .090
KP .687
Dosis 2 Dosis 3 .683
KP .521
Dosis 3 KP .521

3. JAM KE-8
Tests of Normality

Kolmogorov-Smirnova Shapiro-Wilk

Kelompok Statistic df Sig. Statistic df Sig.

Neutrofil Kontrol Negatif .221 6 .200* .872 6 .232

Dosis 1 .406 6 .003 .665 6 .003

Dosis 2 .239 6 .200* .851 6 .162

Dosis 3 .285 6 .139 .779 6 .037

Kontrol Positif .237 6 .200* .936 6 .628

*. This is a lower bound of the true significance.

a. Lilliefors Significance Correction
 Test of Homogeneity of Variances
Neutrofil

Levene Statistic df1 df2 Sig.

.468 4 25 .759

Test Statisticsa,b

Neutrofil

Chi-Square 7.997
df 4
Asymp. Sig. .092

a. Kruskal Wallis Test

b. Grouping Variable:
Kelompok

Mann-Whitney Test
I (Dosis) II (Dosis) Asymp. Sig.
KN Dosis 1 .055
Dosis 2 .053
Dosis 3 .092
KP .078
Dosis 1 Dosis 2 .076
Dosis 3 .065
KP .520
Dosis 2 Dosis 3 .809
KP .809
Dosis 3 KP .686

4. JAM KE-12
Tests of Normality

Kolmogorov-Smirnova Shapiro-Wilk

Kelompok Statistic df Sig. Statistic df Sig.

Neutrofil Kontrol Negatif .343 6 .027 .805 6 .065

Dosis 1 .267 6 .200* .910 6 .439

Dosis 2 .221 6 .200* .926 6 .548

Dosis 3 .187 6 .200* .966 6 .866

Kontrol Positif .190 6 .200* .882 6 .277

*. This is a lower bound of the true significance.

a. Lilliefors Significance Correction
 Test of Homogeneity of Variances
Neutrofil

Levene Statistic df1 df2 Sig.

.425 4 25 .789

ANOVA
Neutrofil

Sum of Squares df Mean Square F Sig.

Between Groups 241.467 4 60.367 2.561 .063

Within Groups 589.333 25 23.573
Total 830.800 29

Multiple Comparisons
Dependent Variable: Neutrofil
LSD

Mean Difference 95% Confidence Interval

(I) Kelompok (J) Kelompok (I-J) Std. Error Sig. Lower Bound Upper Bound

Kontrol Negatif Dosis 1 7.667* 2.803 .011 1.89 13.44

Dosis 2 7.000* 2.803 .019 1.23 12.77

Dosis 3 6.667* 2.803 .025 .89 12.44

Kontrol Positif 6.833* 2.803 .022 1.06 12.61

Dosis 1 Kontrol Negatif -7.667* 2.803 .011 -13.44 -1.89
Dosis 2 -.667 2.803 .814 -6.44 5.11
Dosis 3 -1.000 2.803 .724 -6.77 4.77
Kontrol Positif -.833 2.803 .769 -6.61 4.94
Dosis 2 Kontrol Negatif -7.000* 2.803 .019 -12.77 -1.23
Dosis 1 .667 2.803 .814 -5.11 6.44
Dosis 3 -.333 2.803 .906 -6.11 5.44
Kontrol Positif -.167 2.803 .953 -5.94 5.61
Dosis 3 Kontrol Negatif -6.667* 2.803 .025 -12.44 -.89
Dosis 1 1.000 2.803 .724 -4.77 6.77
Dosis 2 .333 2.803 .906 -5.44 6.11
Kontrol Positif .167 2.803 .953 -5.61 5.94
Kontrol Positif Kontrol Negatif -6.833* 2.803 .022 -12.61 -1.06

Dosis 1 .833 2.803 .769 -4.94 6.61

Dosis 2 .167 2.803 .953 -5.61 5.94

Dosis 3 -.167 2.803 .953 -5.94 5.61

*. The mean difference is significant at the 0.05 level.